|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Aug―02 |
An increased prevalence of carbapenem-resistant hypervirulent Klebsiella pneumoniae associated with the COVID-19 pandemic |
Chao Liu, Jun Guo, Shuaihua Fan, Wei Guo, Huaiqing Qi, Stephen Baker, et al. (+2) Pengcheng Du, Bin Cao |
2 |
[GO] |
2023―Dec―27 |
Vaccine effects on COVID-19 infection with bivalent boosting by age group |
Yoshiyasu Takefuji |
3 |
[GO] |
2023―Sep―22 |
Antibody evasion associated with the RBD significant mutations in several emerging SARS-CoV-2 variants and its subvariants |
Manojit Bhattacharya, Srijan Chatterjee, Sang-Soo Lee, Kuldeep Dhama, Chiranjib Chakraborty |
4 |
[GO] |
2023―Jul―31 |
Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment. |
Daniele Focosi, Scott McConnell, David J. Sullivan, Arturo Casadevall |
5 |
[GO] |
2023―Jun―27 |
New emerging SARS-CoV-2 variants and antiviral agents |
A. Vitiello, A. Zovi, G. Rezza |
6 |
[GO] |
2021―Dec―09 |
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment |
Sylwester Drożdżal, Jakub Rosik, Kacper Lechowicz, Filip Machaj, Bartosz Szostak, Jarosław Przybyciński, et al. (+4) Shahrokh Lorzadeh, Katarzyna Kotfis, Saeid Ghavami, Marek J. Łos |
7 |
[GO] |
2020―Oct―24 |
COVID-19 update: The race to therapeutic development |
Julianne D. Twomey, Shen Luo, Alexis Q. Dean, William P. Bozza, Ancy Nalli, Baolin Zhang |
8 |
[GO] |
2020―Aug―26 |
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses |
Anna Artese, Valentina Svicher, Giosuè Costa, Romina Salpini, Velia Chiara Di Maio, Mohammad Alkhatib, et al. (+5) Francesca Alessandra Ambrosio, Maria Mercedes Santoro, Yehuda G. Assaraf, Stefano Alcaro, Francesca Ceccherini-Silberstein |
9 |
[GO] |
2020―Jul―15 |
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy |
Sylwester Drożdżal, Jakub Rosik, Kacper Lechowicz, Filip Machaj, Katarzyna Kotfis, Saeid Ghavami, Marek J. Łos |